Could inclusion of measuring psoriatic arthritis symptoms in psoriasis clinical trials be a step towards reducing the gap in diagnosis of PsA? That's a question asked of renowned rheumatologist and NPF Board Member, Dr. Elaine Husni, Vice Chair of the Department of Rheumatic and Immunologic Diseases and Director of the Arthritis and Musculoskeletal Center at the Cleveland Clinic. Hear this discussion of the JAAD article "Measuring Psoriatic Arthritis Symptoms: A Core Domain in Psoriasis Clinical Trials". To view disclosure information and claim credit, go to https://www.eeds.com/em/1275 . Article link: https://pubmed.ncbi.nlm.nih.gov/31163240/ .